Growing evidence from major trials shows semaglutide offers substantial protection against heart attacks and strokes for people with overweight or obesity and existing cardiovascular disease. At the same time, people who use Ozempic and related drugs to lose weight report facing more social judgement than those who stay heavier or slim down through diet and exercise alone.
This Ozempic stigma appears rooted in views that medication represents an easy way out rather than a legitimate medical intervention. Prescription volumes have risen sharply in recent years.
